Found 100 matching trials
Clopidogrel Response and CYP2C19 Genotype in Ischemic Stroke Patients PHASE4 Personalized therapy as prophylaxis in ischemic stroke patients is not yet ...
Show More Location
Zealand University Hospital, dept of neurology
Learn More & Join Trial
Genotype Guided Antiplatelet Therapy In Ischemic Stroke NA A fifth of ischemic stroke or transient ischemic attack (TIA) patients will...
Show More Status
Active Not Recruiting
Location
Singapore General Hospital
Learn More & Join Trial
Implementation of Personalized Medicine for Optimal Drug Therapy in Cancer N/A A prospective longitudinal cohort study that will assess the effect of a Pe...
Show More Location
Lawson Health Research Institute
Learn More & Join Trial
Clopidogrel Preventive Effect Based on CYP2C19 Genotype in Ischemic Stroke N/A The hypothesis of this study is that "the poor metabolizer or intermediate ...
Show More Location
Yongin Severance Hospital
Learn More & Join Trial
Spartan Cube CYP2C19 Inter Laboratory Reproducibilty Study NA The study verifies that the Spartan Cube CYP2C19 System generates reproduci...
Show More Location
Children's Hospital of Eastern Ontario
Learn More & Join Trial
Cost-effectiveness of Genotype Guided Treatment With Antiplatelet Drugs in STEMI Patients: Optimization of Treatment (POPular Genetics) PHASE4 Rationale: the use of antiplatelet drugs (i.e. clopidogrel, ticagrelor or p...
Show More Learn More & Join Trial
Biological Collection for the Purpose of Exploring Genetic and Clinical-biological Factors Associated With Variability in Response to Mavacamten in the Treatment of Obstructive Hypertrophic Cardiomyopathy N/A The European Medicines Agency has required pre-treatment genotyping of CYP2...
Show More Location
APHP, Ambroise Paré
Learn More & Join Trial
Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-function: a Validation Study PHASE4 Polymorphisms of the cytochrome P450 (CYP) 2C19 enzyme has been consistentl...
Show More Location
University of Florida
Learn More & Join Trial
Influence of CYP2C19 Genetic Variants on Clopidogrel in Healthy Subjects PHASE1 To test pharmacodynamic response to clopidogrel 150mg once daily during 7 d...
Show More Location
Hôpital Européen Georges Pompidou
Learn More & Join Trial
Pharmacokinetics of Voriconazole in Adult ECMO Patients N/A Given the high burden of fungal co-infection in patients admitted to ICU an...
Show More Location
University Hospitals of Leicester
Learn More & Join Trial